VOPROSY MEDITSINSKOI KHIMII (ISSN 0042-8809)

Characteristics of lipoprotein metabolism impairments in nephrotic syndrome

   
Titov V.N., Tvorogova M.G., Levitova E.N., Krylova E.A.
PubMed Id: 6858031
Year: 1983  Volume: 29  Issue: 2  Pages: 17-23
Hyperlipoproteinemia corresponding to the IIb type was developed in the most patients with diffuse chronic glomerulonephritis and nephrotic syndrome. In blood concentration of very low density lipoproteins (VLDL) was increased with simultaneous accumulation of cholesterol in the fraction. Under conditions of nephrotic syndrome most distinct increase of the Sf 20-12 fraction and content of triglycerides, as compared with the Sf 12-0 fraction, was found in lipoproteins of low density (LDL) Content of cholesterol in high density lipoproteins (HDL) was decreased as compared with donor blood. Activity of postheparin lipoprotein lipase decreased in the most patients. Inspite of cholesterol accumulation in VLDL, triglycerides containing in the Sf 400-100 fraction of the patients were hydrolyzed by rat lipoprotein lipase at the high rate; hence, alteration of VLDL composition should be considered as a factor responsible for impairment of lipoprotein metabolism in blood. Content of VLDL was increased in blood of the patients within the first week of dexamethasone treatment. Within the subsequent period the hormone exhibited distinct hypolipidemic effect. In presence of the hormone heparin-dependent lipoprotein lipase was activated. Increase of lipolytic activity was observed in urine of patients simultaneously with distinct proteinuria.
Download PDF:
Reference:

Titov V.N., Tvorogova M.G., Levitova E.N., Krylova E.A. (1983) Voprosy meditsinskoi khimii, 29(2), 17-23.
References
 1984 (vol 30)
 1983 (vol 29)
 1982 (vol 28)
 1981 (vol 27)
 1980 (vol 26)
 1979 (vol 25)
 1978 (vol 24)
 1977 (vol 23)
 1976 (vol 22)
 1975 (vol 21)
 1974 (vol 20)
 1973 (vol 19)
 1972 (vol 18)
 1971 (vol 17)
 1970 (vol 16)
 1969 (vol 15)
 1968 (vol 14)
 1967 (vol 13)
 1966 (vol 12)
 1965 (vol 11)
        

© Institute of Biomedical Chemistry, Moscow, Russia